Correction to: Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma
J Cancer Res Clin Oncol. 2019 Sep;145(9):2411.
doi: 10.1007/s00432-019-02980-6.
1 Department of Radiotherapy, Policlinico Umberto I, "Sapienza" University of Rome, Rome, Italy.
2 Research Center, Italfarmaco SpA, Cinisello Balsamo, Milan, Italy.
3 Radiobiology Laboratory, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, Via vetoiossnc, Coppito II, L'aquila, Italy.
4 Laboratory of Pharmacology, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'aquila, Italy.
5 Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.
6 Division of Radiation Oncology, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'aquila, Italy.
7 Department of Experimental Medicine, "Sapienza" University of Rome, Rome, Italy.
8 Experimental Pharmacology Unit, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Naples, Italy.
9 Radiobiology Laboratory, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, Via vetoiossnc, Coppito II, L'aquila, Italy. claudio.festuccia@univaq.it.
In the original publication, the 6th author's first name and the last name was inverted and incorrectly published. The correct author name is Letizia Ferella.